Diffuse Type In-Stent Restenosis After Drug-Eluting Stent

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

October 31, 2011

Conditions
In-stent Restenosis
Interventions
DEVICE

Cypher

sirolimus-eluting stent

DEVICE

Xience-V

everolimus-eluting stent

Trial Locations (15)

Unknown

Soonchunhyang University Bucheon Hospital, Bucheon-si

Choeng Ju St.Mary's Hospital, Choeng Ju

Kangwon National University Hospital, Chuncheon

Asan Medical Center, Gangneung

DongGuk University Gyongju Hospital, Gyongju

Chonbuk National University Hospital, Jeonju

Kwangju Christian Hospital, Kwangju

Inje University Pusan Paik Hospital, Pusan

Hallym University Sacred Heart Hospital,, Pyeongchon

Hallym University Sacred Heart Hospital, Pyeongchon

Hangang Sacred Heart Hospital, Seoul

Kyungsang University Hospital, Seoul

Seoul Veterans Hospital, Seoul

Ulsan University Hospital, Ulsan

138-736

Asan Medical Center, Seoul

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

Seung-Jung Park

OTHER

NCT00485030 - Diffuse Type In-Stent Restenosis After Drug-Eluting Stent | Biotech Hunter | Biotech Hunter